Founded in 2010, Genemedi is a technical service company focusing on the research and development of AAV, adenoviral and lentiviral productions. We strive to make contributions to the development and clinical transformation of gene therapy technology, which is important for the whole human being.

Genemedi has established a standardized quality control system and passed the ISO9001: 2009 quality technical body certification. In addition, we have 15 software copyrights, 1 authorized patent, and application for invention 6 patents and 6 utility model patents.

As a professional technical service company for gene function research, Genemedi provides honest and high-quality services for scientists and pharmaceutical companies in life sciences. More than 200 articles have used Genemedi's services and products.

Genemedi has launched a professionally packaging technology service of adeno-associated virus (AAV), adenovirus and lentivirus. A variety of recombinant viral packaging systems are generated for customers. All the viruses from Genemedi are inspected to ensure the excellent quality and high purity. Viral vectors produced in Genemedi can be used both in vitro and in vivo, maximally meeting the demands from customers. Meanwhile, Genemedi has manufactured and released into market the largest number of human full length protein coding ORF cDNA clones in multiple sets of vector systems with various features which make these clones suitable for a variety of functional assays, protein expression and easy purification in many cell types as well as cell free transcription and translation coupling systems, and large scale functional genomics and proteomics studies.